Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
about
Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsyApproaches to canine health surveillanceTreatment in canine epilepsy--a systematic reviewPrevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in EnglandEvidence in Practice - A Pilot Study Leveraging Companion Animal and Equine Health Data from Primary Care Veterinary Clinics in New Zealand.Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.Prevalence of disorders recorded in dogs attending primary-care veterinary practices in England.International Veterinary Epilepsy Task Force consensus reports on epilepsy definition, classification and terminology, affected dog breeds, diagnosis, treatment, outcome measures of therapeutic trials, neuroimaging and neuropathology in companion anInternational veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals.International Veterinary Epilepsy Task Force's current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogsInternational Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocolEfficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.ADAM23 is a common risk gene for canine idiopathic epilepsy.Prognostic value of early magnetic resonance imaging in dogs after traumatic brain injury: 50 cases.Association between estrus and onset of seizures in dogs with idiopathic epilepsy.Idiopathic epilepsy in the Italian Spinone in the United Kingdom: prevalence, clinical characteristics, and predictors of survival and seizure remissionEvaluation of quality of life of carers of Italian spinoni with idiopathic epilepsy.Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs.Canine versus human epilepsy: are we up to date?Concise review: Stem cell trials using companion animal disease models.Epidemiology of Cranial Cruciate Ligament Disease Diagnosis in Dogs Attending Primary-Care Veterinary Practices in England.Mushroom toxicosis: cause or confounder in seasonal canine illness?Cerebral glucose utilization measured with high resolution positron emission tomography in epileptic Finnish Spitz dogs and healthy dogs.Diffusion-weighted imaging of the brains of dogs with idiopathic epilepsy.Border Terriers under primary veterinary care in England: demography and disorders.Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.Cognitive dysfunction in naturally occurring canine idiopathic epilepsy.Phenobarbital administration every eight hours: improvement of seizure management in idiopathic epileptic dogs with decreased phenobarbital elimination half-life.Exploring the pathogenesis of canine epilepsy using a systems genetics method and implications for anti-epilepsy drug discovery.Prevalence, duration and risk factors for appendicular osteoarthritis in a UK dog population under primary veterinary care.Canine epilepsy: separating the wood from the trees.Population pharmacokinetics of extended-release levetiracetam in epileptic dogs when administered alone, with phenobarbital or zonisamideSeizure occurrence in dogs under primary veterinary care in the UK: prevalence and risk factors
P2860
Q21558792-3527ABEB-AF4D-4FB5-AF08-BACA6EB76C68Q24288900-2C4969F1-2E37-41BF-A32B-00476CA3DB51Q27012923-8C98E418-819B-45A7-A4E0-B40E73D1DAE7Q28601642-DFFF1AA5-5CB1-4F98-96A1-6EA1F53B0146Q31153605-88D09DA9-85CC-457C-8A88-5E55E1D4E121Q34795269-B4357587-85FF-4EC0-A28F-CBC24F3FF0A8Q35110634-A393581F-479D-4F3D-8CF8-1C6012FC203AQ35758257-BA857F9D-2B96-4FF8-B9EC-99B4EA5A89EDQ35758281-6EE41FC3-46C0-4FE0-B2C9-7410CFF09E47Q35758330-83988773-1372-43E6-81E7-EDB09A80DE3CQ35759518-1825E599-F41A-4DEC-8F4A-C6E76B71C9D8Q35761727-D30149A6-333D-4FBB-AF62-A207A7DC1440Q36255606-BCE1A6AD-8453-490E-8F0F-4E2674987023Q36259210-2F9933D4-3439-46F2-A510-7044B0F653A3Q36265271-6E0F9EFC-A00C-4A1B-9F9E-9A5B0CC57236Q36873183-E6E799BA-7505-4F1F-9948-D5D5881C93D7Q36873656-238BFDC1-D6ED-4883-BB00-019BBB8D6912Q36974900-984B93F9-6156-4DDA-853D-DD78AC76F2E9Q37063530-BB1F602E-F71B-4417-983E-2AF4E48BF396Q38200540-2856DCC9-37AF-4D54-8565-1CE7F7B2124AQ38592689-C3FCF3C8-25A6-4F98-90FD-63E6E479A6FDQ38756758-D7632655-A128-49F9-B282-34B8968553B4Q38804858-BF4D85A4-053B-4F3D-805B-DD545173A48BQ38990704-9FBE5559-9766-4016-A75D-61E0C94FA8B9Q44898780-66E9EFF4-5473-4F00-9455-F1D3182A96D1Q46930580-BF0E9C56-A3F3-406D-86DB-D7807C6AB356Q47139905-357E7DAE-3BA8-48CA-B0C4-3D0A66EE108CQ47143516-539220E1-281B-40C6-9DF8-3B596D34261CQ48199908-01025238-36D8-470D-9BAB-D4D6C901744CQ50114275-CF4771BC-1F39-4DD0-94D7-9CB3705E9C69Q50965623-BAFBB7B5-F6DC-40C6-A95A-56E847FB1372Q52345443-CA7F8219-5511-443C-A459-4E6AB8FC1017Q52802210-4329DF51-0875-4D4D-8BAA-70C551BCB381Q54274546-892246D2-37E3-4D42-A5A6-C1C6ACDC46ADQ58709296-A7CA67F0-5762-43C3-929A-B3C075C34966Q58738165-56D73893-A243-4B3E-9ADC-6D4215870810
P2860
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
@en
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
@nl
type
label
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
@en
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
@nl
prefLabel
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
@en
Prevalence and risk factors for canine epilepsy of unknown origin in the UK.
@nl
P50
P356
P1433
P1476
Prevalence and risk factors for canine epilepsy of unknown origin in the UK
@en
P2093
D B Church
P356
10.1136/VR.101133
P407
P577
2013-01-07T00:00:00Z